Year
2023
-
FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season
-
Vertex secures FDA clearance for infants’ cystic fibrosis therapy
-
Boehringer Ingelheim Earns Breakthrough Therapy Designation for Pustular Psoriasis Drug
-
Podophyllotoxin – Featured Structure of the Month
-
Viriom Announces Receipt of Funding from the Skolkovo Foundation, ChemRar and Torrey Pines Investment to Develop Elpida®, a Novel Preventive and Long-acting Treatment of HIV/AIDS
-
NewVac Reports Primary Endpoint Met in Phase II Clinical Trial of Quisinostat in Platinum-Resistant Ovarian Cancer
-
Regen BioPharma Begins Optimization of NR2F6 Small Molecule Modulators
-
ChemDiv to Help Afraxis Advance Synaptic Profiling Platform for CNS Drug Discovery
-
ChemDiv Achieves Milestone in Viriom Collaboration on Elsulfavirine/VM1500A Long Acting Injectable Formulation Development
-
Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS